These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 32778874)

  • 1. Pathogenetic profiling of COVID-19 and SARS-like viruses.
    Nain Z; Rana HK; Liò P; Islam SMS; Summers MA; Moni MA
    Brief Bioinform; 2021 Mar; 22(2):1175-1196. PubMed ID: 32778874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease.
    Akaji K; Konno H
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32867349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing host cellular receptor-angiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection.
    Zhuang MW; Cheng Y; Zhang J; Jiang XM; Wang L; Deng J; Wang PH
    J Med Virol; 2020 Nov; 92(11):2693-2701. PubMed ID: 32497323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients.
    Yashavantha Rao HC; Jayabaskaran C
    J Med Virol; 2020 Jul; 92(7):786-790. PubMed ID: 32320066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities.
    Delcuve GP; Lakowski TM; Su RC; Beacon TH; Davie JR
    IUBMB Life; 2020 Nov; 72(11):2313-2330. PubMed ID: 32918855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review.
    Liya G; Yuguang W; Jian L; Huaiping Y; Xue H; Jianwei H; Jiaju M; Youran L; Chen M; Yiqing J
    APMIS; 2020 Jun; 128(6):423-432. PubMed ID: 32363707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing.
    Krishnamoorthy P; Raj AS; Roy S; Kumar NS; Kumar H
    Comput Biol Med; 2021 Jan; 128():104123. PubMed ID: 33260034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses.
    Kirtipal N; Bharadwaj S; Kang SG
    Infect Genet Evol; 2020 Nov; 85():104502. PubMed ID: 32798769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topological Analysis for Sequence Variability: Case Study on more than 2K SARS-CoV-2 sequences of COVID-19 infected 54 countries in comparison with SARS-CoV-1 and MERS-CoV.
    Sarkar JP; Saha I; Seal A; Maity D; Maulik U
    Infect Genet Evol; 2021 Mar; 88():104708. PubMed ID: 33421654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three Emerging Coronaviruses in Two Decades.
    Guarner J
    Am J Clin Pathol; 2020 Mar; 153(4):420-421. PubMed ID: 32053148
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative pathology, molecular pathogenicity, immunological features, and genetic characterization of three highly pathogenic human coronaviruses (MERS-CoV, SARS-CoV, and SARS-CoV-2).
    Rabaan AA; Mutair AA; Alawi ZA; Alhumaid S; Mohaini MA; Aldali J; Tirupathi R; Sule AA; Koritala T; Adhikari R; Bilal M; Dhawan M; Mohapatra RK; Tiwari R; Sami SA; Mitra S; Pandey MK; Harapan H; Emran TB; Dhama K
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7162-7184. PubMed ID: 34859882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
    Ahmed FF; Reza MS; Sarker MS; Islam MS; Mosharaf MP; Hasan S; Mollah MNH
    PLoS One; 2022; 17(4):e0266124. PubMed ID: 35390032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): rapid systematic review and field synopsis.
    Di Maria E; Latini A; Borgiani P; Novelli G
    Hum Genomics; 2020 Sep; 14(1):30. PubMed ID: 32917282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral Infections of the Upper Airway in the Setting of COVID-19: A Primer for Rhinologists.
    Yuen E; Gudis DA; Rowan NR; Nguyen SA; Schlosser RJ
    Am J Rhinol Allergy; 2021 Jan; 35(1):122-131. PubMed ID: 32762250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.
    Stukalov A; Girault V; Grass V; Karayel O; Bergant V; Urban C; Haas DA; Huang Y; Oubraham L; Wang A; Hamad MS; Piras A; Hansen FM; Tanzer MC; Paron I; Zinzula L; Engleitner T; Reinecke M; Lavacca TM; Ehmann R; Wölfel R; Jores J; Kuster B; Protzer U; Rad R; Ziebuhr J; Thiel V; Scaturro P; Mann M; Pichlmair A
    Nature; 2021 Jun; 594(7862):246-252. PubMed ID: 33845483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of the novel coronavirus SARS-CoV-2 and potential anti-COVID19 pharmacological targets since the outbreak of the pandemic.
    Vlachakis D; Papakonstantinou E; Mitsis T; Pierouli K; Diakou I; Chrousos G; Bacopoulou F
    Food Chem Toxicol; 2020 Dec; 146():111805. PubMed ID: 33038452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
    Ye ZW; Jin DY
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.